Literature DB >> 15160360

Imatinib mesylate causes hypopigmentation in the skin.

Kin Wah Leong, Thoong Chow Lee, Ai Sim Goh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15160360     DOI: 10.1002/cncr.20267

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  4 in total

1.  Cutaneous adverse effects associated with the tyrosine-kinase inhibitor cabozantinib.

Authors:  Rena C Zuo; Andrea B Apolo; John J DiGiovanna; Howard L Parnes; Corrine M Keen; Swati Nanda; William L Dahut; Edward W Cowen
Journal:  JAMA Dermatol       Date:  2015-02       Impact factor: 10.282

2.  Familial gastrointestinal stromal tumors with KIT germline mutation in a Chinese family: A case report.

Authors:  Wei Yuan; Wen Huang; Lei Ren; Chen Xu; Li-Juan Luan; Jie Huang; An-Wei Xue; Yong Fang; Xiao-Dong Gao; Kun-Tang Shen; Jing-Huan Lv; Ying-Yong Hou
Journal:  World J Clin Cases       Date:  2022-05-26       Impact factor: 1.534

3.  Efficacy and prognosis of chronic myeloid leukemia treated with imatinib mesylate in a Chinese population.

Authors:  Yanmin Zhao; Lizhen Liu; Yingjia Wang; Gongqiang Wu; Xiaoyu Lai; Weijie Cao; Yi Luo; Yamin Tan; Jimin Shi; Wanzhuo Xie; Xiujin Ye; Zhen Cai; Maofang Lin; He Huang
Journal:  Int J Hematol       Date:  2009-04-07       Impact factor: 2.490

Review 4.  European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.

Authors:  J L Steegmann; M Baccarani; M Breccia; L F Casado; V García-Gutiérrez; A Hochhaus; D-W Kim; T D Kim; H J Khoury; P Le Coutre; J Mayer; D Milojkovic; K Porkka; D Rea; G Rosti; S Saussele; R Hehlmann; R E Clark
Journal:  Leukemia       Date:  2016-04-28       Impact factor: 11.528

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.